about
Vaccination for hepatitis C virus: closing in on an evasive targetRole of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1Prevention and Management of Chronic Hepatitis BNatural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impactsGenomic Diversity of Hepatitis B Virus Infection Associated With Fulminant Hepatitis B DevelopmentHepatitis B Virus Infection, MicroRNAs and Liver DiseaseMicroRNAs may solve the mystery of chronic hepatitis B virus infectionThe naturally occurring YMDD mutation among patients chronically infected HBV and untreated with lamivudine: a systematic review and meta-analysisEmerging hepatitis B virus infection in vaccinated populations: a rising concern?Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factorsCombination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cellsApplications of human hepatitis B virus preS domain in bio- and nanotechnology.Adult immunization-Need of the hourKidney Transplantation From Donors with Hepatitis BInduced immunity against hepatitis B virusCationic lipid-formulated DNA vaccine against hepatitis B virus: immunogenicity of MIDGE-Th1 vectors encoding small and large surface antigen in comparison to a licensed protein vaccineInhibition of hepatitis B virus gene expression & replication by crude destruxins from Metarhizium anisopliae var. dcjhyiumAnti-HBV efficacy of combined siRNAs targeting viral gene and heat shock cognate 70.Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in Qidong, China.Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries.A sensitive and rapid assay for investigating vertical transmission of hepatitis B virus via male germ line using EGFP Vector as reporter.Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, and Syphilis among Blood Donors at Jigjiga Blood Bank, Eastern Ethiopia.A comparative analysis of gene expression patterns and cell phenotypes between cervical and peripheral blood mononuclear cells.Identification of Novel A2/C2 Inter-Genotype Recombinants of Hepatitis B Virus from a Korean Chronic Patient Co-Infected with Both Genotype A2 and C2.Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL.Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner.Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer.Association between hepatitis B virus infection and metabolic syndrome: a retrospective cohort study in Shanghai, China.Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion methodMutations in pre-core and basal-core promoter regions of hepatitis B virus in chronic HBV patients from Golestan, Iran.Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: a nationwide cohort studyHepatitis B virus: where do we stand and what is the next step for eradication?Multiple variants in UGT1A1 gene are factors to develop indirect hyper-bilirubinemiaDetection of hepatitis B virus genotypes using oligonucleotide chip among hepatitis B virus carriers in Eastern China.Disease-free survival after hepatic resection in hepatocellular carcinoma patients: a prediction approach using artificial neural network.Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infectionIdentification of an effective siRNA target site and functional regulatory elements, within the hepatitis B virus posttranscriptional regulatory element.Large fragment pre-S deletion and high viral load independently predict hepatitis B relapse after liver transplantation.Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection.
P2860
Q22305922-BCB5539B-6659-487E-89E0-8CFE61D57272Q24320028-FFE0B06E-6A53-42D8-B30C-29295F5C6E88Q26775726-EFEE6B0F-C9C2-4BB9-A66B-60B4D2FD0212Q26781165-CA054395-ACED-40B0-B9D8-45E4598162CCQ26796488-F3FB9E3E-830B-4BDA-87CC-DD5DE4E6A16CQ26801511-B4820CD4-6296-44C2-A242-74C0A43AE73DQ26827668-D30FFBFE-410C-4952-84AF-37E04F8C294EQ27007658-22A0405E-C56B-4CF5-8D06-E663CA722EE7Q27012663-03FD7C74-D732-4F3B-B80C-A1CF9793B8C4Q27302970-19380858-3ADE-4693-A5A4-81B3DF19E1B7Q27489094-79E2FA2A-E16C-4F4D-9BA4-A25E7FE1FD79Q27693188-9E326E0A-9E55-4C19-90CF-0B886AD32F15Q28077096-B966B90F-A8B1-4733-9AF0-0FBCBDAD73E3Q28079212-DFF82196-4D50-4E6F-BA5C-69AAC4A4B60AQ28080525-18021E16-D6B4-4480-8448-E3469EBE7E87Q28656316-49A00D1D-1A93-4FD6-86C5-2EE6EC55C615Q28660336-296C9ECE-CA3D-473C-86B3-A8F234B62CBBQ30531035-6B2A6980-6B9B-4F28-819F-1EC0B6E78A83Q31161563-2D6A1900-C3DF-4F77-9F78-D02D0F39E6F7Q33318588-6FDCB44D-5782-415A-9F13-8BA156857CFCQ33356604-ADE8F987-874E-49ED-90C5-0BA537E1536FQ33458273-8AC6C32C-7AE9-48C5-80E3-368EF4B8C4F3Q33518544-376C2B3B-C37E-4F1B-8C3B-47D2F4A352ADQ33624430-49E5CF02-9BC5-4382-8A0E-3D189F3EF62CQ33686951-C583C2A5-0DD0-49FC-B17E-4E9951ABEDAEQ33686965-0E92C711-E58D-4D25-AA6C-452E7CA8166AQ33689478-0EAA4D80-E15F-40FD-9A46-10C276DF7805Q33713555-AD1511E7-C8ED-45D9-9793-022A8F05D98EQ33716406-1AE2D0AB-6C77-411B-A8CF-AAFA08B9E0E9Q33802585-7B21DA9B-26E0-454E-973A-F29048FC391EQ33866448-B0151C50-01D2-4F04-9A94-A06AADF83D21Q33904007-D2671FE0-8672-4B3C-8AED-EE9E9FBE3527Q33958764-5FCD9E83-0374-4192-BEBB-6578A59A0C96Q34077163-CA2DB7D6-001E-40EE-95D5-BFA0E38AD882Q34099470-54447B57-ACBF-4FF5-892D-008B4E8E13F7Q34123584-4DBFBE7A-4141-474D-904F-B797CF1E54B9Q34130446-E129951C-0BAE-4C75-AEF7-6C231F9E09F0Q34156859-6A6E223D-B8DF-458B-A5DF-5EA49BC8A4E6Q34171703-55D32750-AB6B-479B-8264-88A830D79AE5Q34252890-C4FD57B9-0393-4E6E-B211-1836A8571DCC
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Global control of hepatitis B virus infection.
@ast
Global control of hepatitis B virus infection.
@en
Global control of hepatitis B virus infection.
@nl
type
label
Global control of hepatitis B virus infection.
@ast
Global control of hepatitis B virus infection.
@en
Global control of hepatitis B virus infection.
@nl
prefLabel
Global control of hepatitis B virus infection.
@ast
Global control of hepatitis B virus infection.
@en
Global control of hepatitis B virus infection.
@nl
P1476
Global control of hepatitis B virus infection
@en
P2093
Ding-Shinn Chen
Jia-Horng Kao
P304
P356
10.1016/S1473-3099(02)00315-8
P577
2002-07-01T00:00:00Z